| mRNA |
PD-0332991 |
CCLE |
pan-cancer |
AAC |
-0.13 |
0.006 |
| mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.006 |
| mRNA |
BRD-K75293299 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.006 |
| mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.006 |
| mRNA |
SCH-529074 |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.007 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.008 |
| mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.008 |
| mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.009 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.01 |
| mRNA |
L-685458 |
CCLE |
pan-cancer |
AAC |
-0.12 |
0.01 |